The prevalence of the human papillomavirus in cervix and vagina in low-risk and high-risk populations

Scandinavian Journal of Infectious Diseases

Volumn 36, Issue 6-7, 2004, Pages 456-459

  Baay, Marc ^a   Verhoeven, Veronique ^a   Wouters, Kristien ^a   Lardon, Filip ^a   Van Damme, Pierre ^a   Avonts, Dirk ^a   Van Marck, Eric ^b   Van Royen, Paul ^a   Vermorken, Jan B ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENERAL PRACTITIONER; HEALTH CARE FACILITY; HIGH RISK POPULATION; HUMAN; HYGIENE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PHYSICIAN; PREVALENCE; QUESTIONNAIRE; RISK ASSESSMENT; SAMPLING; STANDARDIZATION; UTERINE CERVICITIS; UTERINE CERVIX EPITHELIUM; VAGINITIS; VIRUS EXAMINATION; WART VIRUS;

ADULT; CERVIX UTERI; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROSTITUTION; RISK FACTORS; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VAGINA;

EID: 4143061393     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540410020677     Document Type: Article

References (20)

1. Macgregor JE, Campbell MK, Mann EM, Swanson KY. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease. Br Med J 1994; 308: 1407-11.
2. Summers A, Fullard B. Improving the coverage and quality of cervical screening: women's views. J Public Health Med 1995; 17: 277-81.
3. Campbell H, MacDonald S, McKiernan M. Promotion of cervical screening uptake by health visitor follow-up of women who repeatedly failed to attend. J Public Health Med 1996; 18: 94-7.
4. Franco EL, Duarte Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. Can Med Assoc J 2001; 164: 1017-25.
5. Hillemanns P, Kimmig R, Huttemann U, Dannecker C, Thaler CJ. Screening for cervical neoplasia by self-assessment for human papillomavirus DNA. Lancet 1999; 354: 1970.
6. Wright TC, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytological screening to detect cervical cancer. JAMA 2000; 283: 81-6.
7. Dzuba IG, Diaz EY, Allen B, Leonard YF, Ponce ECL, Shah KV, et al. The acceptability of self-collected samples for HPV testing vs the pap test as alternatives in cervical cancer screening. J Womens Health Gender Based Med 2002; 11: 265-74.
8. Harper DM, Noll WW, Belloni DR, Cole BF. Randomized clinical trial of PCR-determined human papillomavirus detection methods: self-sampling vs clinician-directed-biological concordance and women's preferences. Am J Obstet Gynecol 2002; 186: 365-73.
9. Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P, et al. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. Can Med Assoc J 2000; 163: 513-8.
10. Verhoeven V, Avonts D, Meheus A, Leven M, Goossens H, van Royen P. Performance of the recommendations of a British advisory group for screening for chlamydia in a sample of women in general practice. J Med Screen 2003; 10: 14-5.
11. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-91.
12. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995; 76: 1057-62.
13. Jacobs MV, van den Brule AJ, Snijders PJ, Helmerhorst TJ, Meijer CJ, Walboomers JM. A non-radioactive PCR enzyme-immunoassay enables a rapid identification of HPV 16 and 18 in cervical scrapes after GP5+/6+PCR. J Med Virol 1996; 49: 223-9.
14. Muller M, Viscidi RP, Sun Y, Guerrero E, Hill PM, Shah F, et al. Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer. Virology 1992; 187: 508-14.
15. Lorenzato FR, Singer A, Ho L, Santos LC, Batista RD, Lubambo TM, Terry G. Human papillomavirus detection for cervical cancer prevention with polymerase chain reaction in self-collected samples. Am J Obstet Gynecol 2002; 186: 962-8.
16. Mak R, van Renterghem L, Cuvelier C. Cervical smears and human papillomavirus typing in sex workers. Sex Transm Infect 2004; 80: 118-20.
17. Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? Sex Transm Dis 2002; 29: 725-35.
18. Melkert PW, Hopman E, van den Brule AJ, Risse EK, van Diest PJ, Bleker OP, et al. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer 1993; 53: 919-23.
19. Kjaer SK, Svare EI, Worm AM, Walboomers JM, Meijer CJ, van den Brule AJ. Human papillomavirus infection in Danish female sex workers: decreasing prevalence with age despite continuously high sexual activity. Sex Transm Dis 2000; 27: 438-45.
20. Van Ham MAPC, Melchers WJG, Hanselaar AGJM, Bekkers RLM, Boonstra H, Massuger LFAG. Fluctuations in prevalence of cervical human papillomavirus in women frequently sampled during a single menstrual cycle. Br J Cancer 2002; 87: 373-6.